老年非小细胞肺癌治疗期间生活空间变化:混合方法队列研究
该混合方法队列研究纳入93例≥65岁晚期非小细胞肺癌患者,在治疗前及治疗后1、2、4、6个月完成生活空间评估(LSA)。治疗前平均LSA为67.1,从治疗前到1个月平均下降10.1分,至6个月保持稳定。高焦虑患者1个月内LSA下降更大,治疗前BMI<21 kg/m²与1至6个月LSA改善相关。
要点
- 晚期NSCLC老年患者治疗前生活空间已偏低,治疗1个月内平均下降10.1分。
- 高焦虑患者治疗1个月内LSA下降更明显(斜率-12.6 vs -2.3,p=0.048)。
- 治疗前BMI<21 kg/m²与1至6个月LSA改善相关(斜率4.1 vs -0.04,p=0.003)。
核心结论
- 老年晚期NSCLC患者治疗前生活空间较低,治疗期间许多人出现生活空间受限。
- 将生活空间评估纳入肿瘤临床照护可能帮助老年患者直观理解治疗对日常功能的影响,以支持知情决策并早期识别活动能力变化。
研究设计与样本
- 混合方法队列研究,招募≥65岁、开始姑息性化疗、免疫治疗和/或靶向治疗的晚期NSCLC成人。
- 患者于治疗前及治疗开始后1、2、4、6个月完成包括LSA在内的老年评估,LSA评分范围0-120分,<60分视为受限。
- 采用混合效应模型分析治疗前LSA、0至1个月变化及1至6个月变化;亚组患者于治疗前及2、6个月接受半结构式访谈。
主要发现
- 共纳入93例患者,中位年龄73岁(范围65-94)。
- 治疗前平均LSA评分为67.1分。
- 平均LSA从治疗前至1个月下降10.1分,至6个月保持稳定。
- 治疗前LSA评分与多项人口学、临床、老年评估及症状特征相关。
- 高焦虑患者1个月内LSA下降更大(斜率-12.6 vs -2.3,p=0.048)。
关键数值与推荐
- LSA评分范围0-120分,评分越高活动能力越好;LSA<60分视为生活空间受限。
- 高焦虑患者1个月内LSA斜率-12.6,非高焦虑患者为-2.3,p=0.048。
- 治疗前BMI<21 kg/m²者1至6个月LSA斜率4.1,对照组为-0.04,p=0.003。
临床怎么用
- 对老年晚期NSCLC患者在治疗前及治疗早期进行LSA评估,可识别生活空间受限及早期活动能力下降。
- 关注高焦虑患者的早期生活空间下降,及时给予支持性干预。
- 结合生活空间评估结果与患者沟通治疗对日常功能的影响,辅助知情决策。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Maintenance of function during cancer treatment is important to older adults. Characteristics associated with pretreatment life-space mobility and changes during non-small cell lung cancer (NSCLC) treatment remain unknown. METHODS: This mixed methods cohort study recruited adults age ≥65 with advanced NSCLC starting palliative chemotherapy, immunotherapy, and/or targeted therapy from a Comprehensive Cancer Center, Veterans Affairs, and safety-net clinic. Patients completed geriatric assessments including Life-Space Assessment (LSA) pretreatment and at 1, 2, 4, and 6 months after treatment initiation. LSA scores range from 0 to 120 (greater mobility); LSA <60 is considered restricted. We used mixed-effects models to examine pretreatment LSA, change from 0 to 1 month, and change from 1 to 6 months. A subgroup participated in semistructured interviews pretreatment and at 2 and 6 months to understand the patient experience of life-space change. For each interview participant, we created joint displays of longitudinal LSA scores juxtaposed with illustrative quotes. RESULTS: Among 93 patients, median age was 73 (range 65-94). Mean pretreatment LSA score was 67.1. On average, LSA declined 10.1 points from pretreatment to 1 month and remained stable at 6 months. Pretreatment LSA score was associated with several demographic, clinical, geriatric assessment, and symptom characteristics. LSA decline at 1 month was greater among patients with high anxiety (slope = -12.6 vs. -2.3, p = 0.048). Pretreatment body mass index <21 kg/m2 was associated with LSA improvement from 1 to 6 months (slope = 4.1 vs. -0.04, p = 0.003). Joint displays illustrated the impact of different life-space trajectories on patients' lives in their words. CONCLUSION: Older adults with NSCLC have low pretreatment life space with many developing restricted life space during treatment. Incorporating life-space assessments into clinical cancer care may help older adults concretely visualize how treatment might impact their daily function to allow for informed decision making and identify early changes in mobility to implement supportive interventions.
引用
- Wong ML, Shi Y, Smith AK, et al. Changes in older adults' life space during lung cancer treatment: A mixed methods cohort study. J Am Geriatr Soc. 2021. PMID: 34611887. doi:10.1111/jgs.17474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。